Clinical outcomes of patients with myelofibrosis after immediate transition to momelotinib from ruxolitinib

Ruben Mesa; Srdan Verstovsek; Uwe Platzbecker; Vikas Gupta; David Lavie; Pilar Giraldo; Christian Recher; Jean Jacques Kiladjian; Stephen T. Oh; Aaron T. Gerds; Timothy Devos; Francesco Passamonti; Alessandro M. Vannucchi; Miklos Egyed; Ewa Lech-Maranda; Andrzej Pluta; Lars Nilsson; Kazuya Shimoda; Donal McLornan; Jun Kawashima; Barbara Klencke; Mei Huang; Bryan Strouse; Claire Harrison

doi:10.3324/HAEMATOL.2023.283106

Clinical outcomes of patients with myelofibrosis after immediate transition to momelotinib from ruxolitinib

Ruben Mesa, Srdan Verstovsek, Uwe Platzbecker, Vikas Gupta, David Lavie, Pilar Giraldo, Christian Recher, Jean Jacques Kiladjian, Stephen T. Oh, Aaron T. Gerds, Timothy Devos, Francesco Passamonti, Alessandro M. Vannucchi, Miklos Egyed, Ewa Lech-Maranda, Andrzej Pluta, Lars Nilsson, Kazuya Shimoda, Donal McLornan, Jun KawashimaBarbara Klencke, Mei Huang, Bryan Strouse, Claire Harrison

Research output: Contribution to journal › Letter › peer-review

5 Scopus citations

Original language	English
Pages (from-to)	676-681
Number of pages	6
Journal	Haematologica
Volume	109
Issue number	2
DOIs	https://doi.org/10.3324/HAEMATOL.2023.283106
State	Published - Feb 2024

Access to Document

10.3324/HAEMATOL.2023.283106

Cite this

Mesa, R., Verstovsek, S., Platzbecker, U., Gupta, V., Lavie, D., Giraldo, P., Recher, C., Kiladjian, J. J., Oh, S. T., Gerds, A. T., Devos, T., Passamonti, F., Vannucchi, A. M., Egyed, M., Lech-Maranda, E., Pluta, A., Nilsson, L., Shimoda, K., McLornan, D., ... Harrison, C. (2024). Clinical outcomes of patients with myelofibrosis after immediate transition to momelotinib from ruxolitinib. Haematologica, 109(2), 676-681. https://doi.org/10.3324/HAEMATOL.2023.283106

@article{243aa06079fd4e60af934cff28c7fa70,

title = "Clinical outcomes of patients with myelofibrosis after immediate transition to momelotinib from ruxolitinib",

author = "Ruben Mesa and Srdan Verstovsek and Uwe Platzbecker and Vikas Gupta and David Lavie and Pilar Giraldo and Christian Recher and Kiladjian, {Jean Jacques} and Oh, {Stephen T.} and Gerds, {Aaron T.} and Timothy Devos and Francesco Passamonti and Vannucchi, {Alessandro M.} and Miklos Egyed and Ewa Lech-Maranda and Andrzej Pluta and Lars Nilsson and Kazuya Shimoda and Donal McLornan and Jun Kawashima and Barbara Klencke and Mei Huang and Bryan Strouse and Claire Harrison",

year = "2024",

month = feb,

doi = "10.3324/HAEMATOL.2023.283106",

language = "English",

volume = "109",

pages = "676--681",

journal = "Haematologica",

issn = "0390-6078",

number = "2",

}

Mesa, R, Verstovsek, S, Platzbecker, U, Gupta, V, Lavie, D, Giraldo, P, Recher, C, Kiladjian, JJ, Oh, ST, Gerds, AT, Devos, T, Passamonti, F, Vannucchi, AM, Egyed, M, Lech-Maranda, E, Pluta, A, Nilsson, L, Shimoda, K, McLornan, D, Kawashima, J, Klencke, B, Huang, M, Strouse, B & Harrison, C 2024, 'Clinical outcomes of patients with myelofibrosis after immediate transition to momelotinib from ruxolitinib', Haematologica, vol. 109, no. 2, pp. 676-681. https://doi.org/10.3324/HAEMATOL.2023.283106

TY - JOUR

T1 - Clinical outcomes of patients with myelofibrosis after immediate transition to momelotinib from ruxolitinib

AU - Mesa, Ruben

AU - Verstovsek, Srdan

AU - Platzbecker, Uwe

AU - Gupta, Vikas

AU - Lavie, David

AU - Giraldo, Pilar

AU - Recher, Christian

AU - Kiladjian, Jean Jacques

AU - Oh, Stephen T.

AU - Gerds, Aaron T.

AU - Devos, Timothy

AU - Passamonti, Francesco

AU - Vannucchi, Alessandro M.

AU - Egyed, Miklos

AU - Lech-Maranda, Ewa

AU - Pluta, Andrzej

AU - Nilsson, Lars

AU - Shimoda, Kazuya

AU - McLornan, Donal

AU - Kawashima, Jun

AU - Klencke, Barbara

AU - Huang, Mei

AU - Strouse, Bryan

AU - Harrison, Claire

PY - 2024/2

Y1 - 2024/2

UR - http://www.scopus.com/inward/record.url?scp=85184141885&partnerID=8YFLogxK

U2 - 10.3324/HAEMATOL.2023.283106

DO - 10.3324/HAEMATOL.2023.283106

M3 - Letter

C2 - 37259556

AN - SCOPUS:85184141885

SN - 0390-6078

VL - 109

SP - 676

EP - 681

JO - Haematologica

JF - Haematologica

IS - 2

ER -

Clinical outcomes of patients with myelofibrosis after immediate transition to momelotinib from ruxolitinib

Access to Document

Other files and links

Cite this